why choose us

First received: November 2, 2022

Clinical Trial: Evaluation of 611 in Chinese Adult Patients With Moderate-to-Severe Atopic Dermatitis

Study Status: Completed

Recruit Status: Completed

Condition: Dermatitis, Atopic

Study Type: Interventional


Official Title: A Randomized, Double-Blind, Placebo-Controlled, Single and Repeated Dose Escalation Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Patients With Moderate-to-Severe Atopic Derma

Brief Summary: The primary objective of the study was to evaluate the safety and tolerability of 611 in chinese adults with moderate to severe atopic dermatitis.

Read more